Danaher Corp (DHR) - Biotechnology Operating Income (I:DCDHRBOI)
Level Chart
Basic Info
|
Danaher Corp (DHR) - Biotechnology Operating Income is at a current level of 390.00M, down from 462.00M last quarter and down from 417.00M one year ago. This is a change of -15.58% from last quarter and -6.47% from one year ago. |
|
Danaher Corp Biotechnology Operating Income refers to the profit or earnings derived from the specific business segment that focuses on providing biotechnology solutions and products within Danaher Corporation. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 390.00M |
| Latest Period | Sep 2024 |
| Last Updated | Oct 31 2024, 08:51 EDT |
| Next Release | Jan 31 2025, 08:30 EST (E) |
| Average Growth Rate | -19.06% |
| Value from Last Quarter | 462.00M |
| Change from Last Quarter | -15.58% |
| Value from 1 Year Ago | 417.00M |
| Change from 1 Year Ago | -6.47% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| September 30, 2024 | 390.00M |
| June 28, 2024 | 462.00M |
| March 31, 2024 | 325.00M |
| December 31, 2023 | 416.00M |
| September 30, 2023 | 417.00M |
| June 30, 2023 | 480.00M |
| March 31, 2023 | 596.00M |
| December 31, 2022 | 693.00M |
| September 30, 2022 | 691.00M |
| July 01, 2022 | 824.00M |
| Date | Value |
|---|---|
| April 01, 2022 | 800.00M |
| December 31, 2021 | 780.00M |
| October 01, 2021 | 0.00 |
| July 02, 2021 | 0.00 |
| April 02, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| July 03, 2020 | 0.00 |
| April 03, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
News
Basic Info
|
Danaher Corp (DHR) - Biotechnology Operating Income is at a current level of 390.00M, down from 462.00M last quarter and down from 417.00M one year ago. This is a change of -15.58% from last quarter and -6.47% from one year ago. |
|
Danaher Corp Biotechnology Operating Income refers to the profit or earnings derived from the specific business segment that focuses on providing biotechnology solutions and products within Danaher Corporation. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 390.00M |
| Latest Period | Sep 2024 |
| Last Updated | Oct 31 2024, 08:51 EDT |
| Next Release | Jan 31 2025, 08:30 EST (E) |
| Average Growth Rate | -19.06% |
| Value from Last Quarter | 462.00M |
| Change from Last Quarter | -15.58% |
| Value from 1 Year Ago | 417.00M |
| Change from 1 Year Ago | -6.47% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
Related Securities
Related Indicators
| Danaher Corp (DHR) - Former Life Sciences Operating Income | 425.00M USD |
| Danaher Corp (DHR) - Former Life Sciences Revenue | 3.435B USD |
| Danaher Corp (DHR) - Life Sciences Operating Income | 35.00M USD |
| Danaher Corp (DHR) - Life Sciences Revenue | 1.782B USD |
| Danaher Corp (DHR) - Non-Recurring Revenue | 1.021B USD |
| Danaher Corp (DHR) - Recurring Revenue | 4.777B USD |